指南与共识其他结缔组织病

干燥病周围神经系统表现评估与管理的临床实践指南

Clinical Practice Guideline for Evaluation and Management of Peripheral Nervous System Manifestations in Sjögren's Disease.
指南 / 共识 · Arthritis Care Res (Hoboken) · 2026-03-08

本指南由风湿病学、神经病学及指南方法学专家组成的专题评审组制定,系统检索PubMed和Embase至2025年7月22日的证据,纳入6项病例系列、1项回顾性队列和2项无对照前瞻性队列研究。指南建立了跨学科统一的PNS术语命名、31条评估良好实践和20条循证治疗推荐,推荐基于GRADE方法评为条件性或强推荐,但因高级别证据稀缺,主要源于专家意见。

要点

  • 建立跨学科统一的PNS术语命名,并给出31条疑似PNS表现评估的良好实践。
  • 提出20条循证治疗推荐,按GRADE方法评为条件性或强推荐。
  • 因高级别证据稀缺,指南推荐主要源于专家意见。

核心结论

  • 本指南为干燥病患者周围神经病的评估、诊断和治疗提供严谨的循证资源,通过专家共识过程制定。
  • 当获益显著超过潜在危害时推荐评为强推荐,此时多数患者会偏好所建议的措施。

研究设计与样本

  • 专题评审组由风湿病学、神经病学和指南方法学专家组成,提出PICO问题并系统综述干燥病PNS表现管理的最佳证据。
  • 检索PubMed和Embase至2025年7月22日的证据,文献筛选、数据提取和批判性评价由两人重复完成。
  • 纳入6项病例系列、1项回顾性队列和2项缺乏对照组的前瞻性队列研究。

主要发现

  • 制定了可跨学科使用的PNS术语统一命名。
  • 制定了31条评估疑似PNS表现的良好实践。
  • 制定了20条循证治疗推荐,按GRADE方法评为条件性或强推荐。
  • 因高级别证据稀缺,本指南主要源于专家意见。

关键数值与推荐

  • 20条循证治疗推荐依据GRADE方法评为条件性或强推荐。
  • 推荐在获益显著超过潜在危害时评为强推荐。

临床怎么用

  • 指南供临床医生用于干燥病患者周围神经病的评估、诊断和治疗。
  • 指南提供跨学科统一的PNS术语命名,可用于不同学科间的沟通。
  • 指南包含31条评估疑似PNS表现的良好实践,供评估时参考。

局限性

  • 因高级别证据稀缺,本指南主要源于专家意见。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Sjögren's disease is an autoimmune disorder that can impact multiple organ systems, including the peripheral nervous system (PNS). PNS manifestations, which can exist concurrently, include mononeuropathies, polyneuropathies, and autonomic nervous system neuropathies. To help patients and providers in the decision-making process, we developed an evidence-based clinical practice guideline for the evaluation and management of PNS manifestations in patients with Sjögren's disease. METHODS: A Topic Review Group, comprising experts in rheumatology, neurology, and guideline methodology, developed Patient, Intervention, Comparison, and Outcome questions and conducted a systematic review to identify the current best evidence on management of PNS manifestations of Sjögren's disease. PubMed and Embase were searched for evidence published up to July 22, 2025. Literature screening, data extraction, and critical appraisal were performed in duplicate. Six case series, one retrospective cohort, and two prospective cohort studies lacking a comparison group met the inclusion criteria. RESULTS: We developed an aligned nomenclature of PNS terms that can be used across disciplines, 31 good practices for evaluation of suspected PNS manifestations, and 20 evidence-based treatment recommendations, the latter of which were rated as conditional or strong based on the Grading of Recommendations Assessment, Development, and Evaluation methodology. Because of the scarcity of high-level evidence, this guideline predominantly derives from expert opinion. CONCLUSION: This clinical practice guideline on PNS manifestations of Sjögren's disease provides clinicians a rigorous, evidence-based resource, developed through an expert consensus-based process, for the assessment, diagnosis, and treatment of peripheral neuropathy in patients with Sjögren's disease. Recommendations were rated as strong when the benefits significantly outweighed potential harms, creating a scenario in which most patients would prefer the advised action.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Deboo A, Fox R, Hammitt KM, et al. Clinical Practice Guideline for Evaluation and Management of Peripheral Nervous System Manifestations in Sjögren's Disease. Arthritis Care Res (Hoboken). 2026. PMID: 41327784. doi:10.1002/acr.70004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。